Spacepro Improves Access Rates and Customer Interaction for Service Appointments using Descartes Customer Engagement Solution 31-10-2023, 17:45

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

Meltwater announces new AI-powered assistants, summaries and analysis at Meltwater Summit 21-06-2023, 23:16